418 related articles for article (PubMed ID: 18721869)
1. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
Van Eerdenbrugh B; Van den Mooter G; Augustijns P
Int J Pharm; 2008 Nov; 364(1):64-75. PubMed ID: 18721869
[TBL] [Abstract][Full Text] [Related]
2. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
Shegokar R; Müller RH
Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
[TBL] [Abstract][Full Text] [Related]
4. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
[TBL] [Abstract][Full Text] [Related]
5. Drug nanocrystals in the commercial pharmaceutical development process.
Möschwitzer JP
Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
[TBL] [Abstract][Full Text] [Related]
6. Stability of nanosuspensions in drug delivery.
Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D
J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372
[TBL] [Abstract][Full Text] [Related]
7. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
Constantinides PP; Chaubal MV; Shorr R
Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
[TBL] [Abstract][Full Text] [Related]
8. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
10. Nanosizing--oral formulation development and biopharmaceutical evaluation.
Kesisoglou F; Panmai S; Wu Y
Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
[TBL] [Abstract][Full Text] [Related]
11. Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property.
Yue PF; Li Y; Wan J; Yang M; Zhu WF; Wang CH
Int J Pharm; 2013 Sep; 454(1):269-77. PubMed ID: 23830942
[TBL] [Abstract][Full Text] [Related]
12. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
13. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
Leone F; Cavalli R
Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.
Zhang X; Li LC; Mao S
Curr Pharm Des; 2014; 20(3):388-407. PubMed ID: 23651400
[TBL] [Abstract][Full Text] [Related]
15. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
16. Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery.
Pardhi VP; Verma T; Flora SJS; Chandasana H; Shukla R
Curr Pharm Des; 2018; 24(43):5129-5146. PubMed ID: 30767737
[TBL] [Abstract][Full Text] [Related]
17. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
[TBL] [Abstract][Full Text] [Related]
18. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
[TBL] [Abstract][Full Text] [Related]
19. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies.
Du J; Li X; Zhao H; Zhou Y; Wang L; Tian S; Wang Y
Int J Pharm; 2015 Nov; 495(2):738-49. PubMed ID: 26383838
[TBL] [Abstract][Full Text] [Related]
20. Nanosuspension Technology For Poorly Soluble Drugs: Recent Researches, Advances and Patents.
Agarwal V; Bajpai M
Recent Pat Nanotechnol; 2015; 9(3):178-94. PubMed ID: 27009133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
